参考文献/References:
[1] Lee DS,Gona P,Albano I,et al. A systematic assessment of causes of death after heart failure onset in the community:impact of age at death,time period,and left ventricular systolic dysfunction[J]. Circ Heart Fail,2011,4(1):36-43.
[2] Bj?rck S,Palaszewski B,Friberg L,et al. Atrial fibrillation,stroke risk,and warfarin therapy revisited:a population-based study[J]. Stroke,2013,44(11):3103-3108.
[3] Lab MJ. Contraction-excitation feedback in myocardium. Physiological basis and clinical relevance[J]. Circ Res,1982,50(6):757-766.
[4] Ponikowski P,Anker SD,Alhabib KF,et al. Heart failure:preventing disease and death worldwide[J]. ESC Heart Fail,2014,1(1):4-25.
[5] Wang H,Chai K,Du M,et al. Prevalence and incidence of heart failure among urban patients in China:a national population-based analysis[J]. Circ Heart Fail,2021,14(10):e008406.
[6] Farmakis D,Chrysohoou C,Giamouzis G,et al. The management of atrial fibrillation in heart failure:an expert panel consensus[J]. Heart Fail Rev,2021,26(6):1345-1358.
[7] Anker SD,Butler J,Filippatos G,et al. Empagliflozin in heart failure with a preserved ejection fraction[J]. N Engl J Med,2021,385(16):1451-1461.
[8] 邹书斌,朱柏祥,张春洋,等.无心衰房颤与房颤合并心衰病人脑卒中发生率的对比研究[J].航空航天医学杂志,2016,27(3):286-287.
[9] Walters TE,Lee G,Spence S,et al. Acute atrial stretch results in conduction slowing and complex signals at the pulmonary vein to left atrial junction:insights into the mechanism of pulmonary vein arrhythmogenesis[J]. Circ Arrhythm Electrophysiol,2014,7(6):1189-1197.
[10] Xie E,Yu R,Ambale-Venkatesh B,et al. Association of right atrial structure with incident atrial fibrillation:a longitudinal cohort cardiovascular magnetic resonance study from the Multi-Ethnic Study of Atherosclerosis (MESA)[J]. J Cardiovasc Magn Reson,2020,22(1):36.
[11] 包丽莲,程蕾,黄国倩,等. 斑点追踪超声心动图评价左房功能及其在房颤中临床价值的研究进展[J]. 复旦学报(医学版),2022,49(04):606-613.
[12] Rucker-Martin C,Milliez P,Tan S,et al. Chronic hemodynamic overload of the atria is an important factor for gap junction remodeling in human and rat hearts[J]. Cardiovasc Res,2006,72(1):69-79.
[13] Shi Y,Li X,Yang J. Cx43 upregulation in HUVECs under stretch via TGF-β1 and cytoskeletal network[J]. Open Med (Wars),2022,17(1):463-474.
[14] Wang J,Chen H,Seth A,et al. Mechanical force regulation of myofibroblast differentiation in cardiac fibroblasts[J]. Am J Physiol Heart Circ Physiol,2003,285(5):H1871-H1881.
[15] Sohns C,Marrouche NF. Atrial fibrillation and cardiac fibrosis[J]. Eur Heart J,2020,41(10):1123-1131.
[16] Jakob D,Klesen A,Allegrini B,et al. Piezo1 and BKCa channels in human atrial fibroblasts :interplay and remodelling in atrial fibrillation[J]. J Mol Cell Cardiol,2021,158:49-62.
[17] Kis K,Liu X,Hagood JS. Myofibroblast differentiation and survival in fibrotic disease[J]. Expert Rev Mol Med,2011,13:e27.
[18] Chang SL,Chen YC,Chen YJ,et al. Mechanoelectrical feedback regulates the arrhythmogenic activity of pulmonary veins[J]. Heart,2007,93(1):82-88.
[19] Hamaguchi S,Hikita K,Tanaka Y,et al. Enhancement of automaticity by mechanical stretch of the isolated guinea pig pulmonary vein myocardium[J]. Biol Pharm Bull,2016,39(7):1216-1219.
[20] Wang Y,Joyner RW,Wagner MB,et al. Stretch-activated channel activation promotes early afterdepolarizations in rat ventricular myocytes under oxidative stress[J]. Am J Physiol Heart Circ Physiol,2009,296(5):H1227-H1235.
[21] Kamkin A,Kiseleva I,Wagner KD,et al. Characterization of stretch-activated ion currents in isolated atrial myocytes from human hearts[J]. Pflugers Arch,2003,446(3):339-346.
[22] Lugenbiel P,Wenz F,Syren P,et al. TREK-1 (K2P2.1) K+ channels are suppressed in patients with atrial fibrillation and heart failure and provide therapeutic targets for rhythm control[J]. Basic Res Cardiol ,2017,112(1):8.
[23] Egorov YV,Lang D,Tyan L,et al. Caveolae-mediated activation of mechanosensitive chloride channels in pulmonary veins triggers atrial arrhythmogenesis[J]. J Am Heart Assoc,2019,8(20):e012748.
[24] Yan Y,Skarsfeldt MA,Diness JG,et al. Small conductance calcium activated K+ channel inhibitor decreases stretch induced vulnerability to atrial fibrillation[J]. Int J Cardiol Heart Vasc ,2021,37:100898.
[25] Zhang Y,Qi Y,Li JJ,et al. Stretch-induced sarcoplasmic reticulum calcium leak is causatively associated with atrial fibrillation in pressure-overloaded hearts[J]. Cardiovasc Res,2021,117(4):1091-1102.
[26] Ravelli F,Masè M, del Greco M,et al. Acute atrial dilatation slows conduction and increases AF vulnerability in the human atrium [J]. J Cardiovasc Electrophysiol,2011,22(4):394-401.
[27] Alcidi G,Goffredo G,Correale M,et al. Brain natriuretic peptide biomarkers in current clinical and therapeutic scenarios of heart failure[J]. J Clin Med,2022,11(11):3192.
[28] Younes H ,Mekhael M,Feng H,et al. Baseline natriuretic peptides as a predictor of atrial fibrillation recurrence after radiofrequency-based pulmonary vein isolation in a non-heart failure population:a subanalysis from DECAAFⅡ[J]. Pacing Clin Electrophysiol,2023,46(8):848-854.
[29] Deferm S,Martens P,Verbrugge FH,et al. LA mechanics in decompensated heart failure:insights from strain echocardiography with invasive hemodynamics[J]. JACC Cardiovasc Imaging,2020,13(5):1107-1115.
[30] Desai AS,McMurray JJ,Packer M,et al. Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients[J]. Eur Heart J,2015,36(30):1990-1997.
[31] Wang R,Ye H,Ma L,et al. Effect of sacubitril/valsartan on reducing the risk of arrhythmia:a systematic review and meta-analysis of randomized controlled trials[J]. Front Cardiovasc Med,2022,9:890481.
[32] Yang E,Tang O,Metkus T,et al. The role of timing in treatment of atrial fibrillation:an AFFIRM substudy[J]. Heart Rhythm,2021,18(5):674-681.
[33] Sohns C,Zintl K,Zhao Y,et al. Impact of left ventricular function and heart failure symptoms on outcomes post ablation of atrial fibrillation in heart failure:CASTLE-AF trial[J]. Circ Arrhythm Electrophysiol,2020,13(10):e008461.
[34] 梁晓芳,李文华,宋艳斌,等. 沙库巴曲缬沙坦对持续性心房颤动导管消融术后临床疗效的影响:基于倾向性评分的单中心队列研究[J]. 临床心血管病杂志,2023,39(09):699-706.
[35] Ishikawa K,Watanabe S,Lee P,et al. Acute left ventricular unloading reduces atrial stretch and inhibits atrial arrhythmias[J]. J Am Coll Cardiol,2018,72(7):738-750.
[36] Lu D,Zhu J,Liao B. Efficacy and safety of inter-atrial shunt devices for heart failure with reduced or preserved ejection fraction:early experiences[J]. Heart Lung Circ,2018,27(3):359-364.
[37] Shah SJ,Borlaug BA,Chung ES,et al. Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HFⅡ):a randomised,multicentre,blinded,sham-controlled trial[J]. Lancet,2022,399(10330):1130-1140.
相似文献/References:
[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(10):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(10):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]丁娟,刘地川.心力衰竭与线粒体功能障碍的研究进展[J].心血管病学进展,2016,(1):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
DING Juan,LIU Dichuan.Research Progress of Heart Failure and Mitochondrial Dysfunction[J].Advances in Cardiovascular Diseases,2016,(10):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
[4]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(10):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[5]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in
Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(10):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[6]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular
Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(10):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[7]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(10):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[8]罗秀林,综述,张烁,等.肾动脉去交感神经术治疗心力衰竭——希望还是炒作[J].心血管病学进展,2016,(3):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
LUO Xiulin,ZHANG Shuo.Renal Sympathetic Denervation for Heart Failure—Hopes or Hypes[J].Advances in Cardiovascular Diseases,2016,(10):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
[9]查凤艳,综述,覃数,等.心源性恶病质发病机制的研究进展[J].心血管病学进展,2016,(3):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
ZHA Fengyan,QIN Shu.Advances in Pathogenesis of Cardiac Cachexia[J].Advances in Cardiovascular Diseases,2016,(10):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
[10]李慧,综述,齐国先,等.老年射血分数保留的心功能不全研究进展[J].心血管病学进展,2016,(4):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
LI Hui,QI Guoxian.Research Progress of Heart Failure with Preserved Ejection Fraction in Elderly People[J].Advances in Cardiovascular Diseases,2016,(10):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
[11]吴彤 高东来.心房颤动合并心力衰竭的射频消融治疗[J].心血管病学进展,2019,(5):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]
WU TongGAO Donglai.Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2019,(10):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]
[12]鲁星琴 莫乔莹 陈凤梅 姚亚丽.睡眠呼吸障碍与心力衰竭并发心房颤动的相关性研究现状[J].心血管病学进展,2020,(2):182.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.021]
LU Xingqin,MO Qiaoying,CHENG Fengmei,et al.Research Status of Association Between Sleep-disordered Breathing and Atrial Fibrillation in Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2020,(10):182.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.021]
[13]史云聪,王立立 郭艺芳.维生素D与心血管疾病相关性研究进展[J].心血管病学进展,2020,(8):826.[doi:10.16806/j.cnki.issn.1004-3934.20.08.011]
SHI YuncongWANG LiliGUO Yifang.Vitamin D And Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(10):826.[doi:10.16806/j.cnki.issn.1004-3934.20.08.011]
[14]李英 刘兴鹏.常见心血管病服药依从性[J].心血管病学进展,2020,(10):1016.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.000]
LI Ying,LIU Xingpeng.Medication Adherence For Common Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2020,(10):1016.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.000]
[15]刘玉辉 王盼盼 陈椿.心房颤动性心肌病临床研究进展[J].心血管病学进展,2020,(12):1238.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.004]
LIU Yuhui,WANG Panpan,CHEN Chun.Atrial Fibrillation-induced Cardiomyopathy[J].Advances in Cardiovascular Diseases,2020,(10):1238.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.004]
[16]徐尧 蔡衡 李洪仕.心房颤动合并心力衰竭的导管消融治疗[J].心血管病学进展,2021,(4):322.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.009]
XU Yao,CAI Heng,LI Hongshi.Role of Radiofrequency Ablation in Patients with Atrial Fibrillation and Heart Failure[J].Advances in Cardiovascular Diseases,2021,(10):322.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.009]
[17]徐尧 蔡衡 李洪仕.射频消融与药物治疗对心房颤动合并心力衰竭患者的疗效差异比较[J].心血管病学进展,2022,(3):274.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
[18]乔宝 魏述建.心房衰竭的临床研究进展[J].心血管病学进展,2024,(1):57.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.015]
QIAO Bao,WEI Shujian.Progress of Clinical Research on Atrial Failure[J].Advances in Cardiovascular Diseases,2024,(10):57.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.015]
[19]陈建福 陈灿.血压目标范围内时间与心血管疾病关系的研究进展[J].心血管病学进展,2024,(7):617.[doi:10.16806/j.cnki.issn.1004-3934.2024.07.010]
CHEN Jianfu,CHEN Can.The Relationship Between Time in Target Range and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2024,(10):617.[doi:10.16806/j.cnki.issn.1004-3934.2024.07.010]